205 related articles for article (PubMed ID: 15913591)
1. Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis.
van Toorenenbergen AW; Oranje AP
Clin Chim Acta; 2005 Sep; 359(1-2):72-7. PubMed ID: 15913591
[TBL] [Abstract][Full Text] [Related]
2. Urinary 11β-PGF2α and N-methyl histamine correlate with bone marrow biopsy findings in mast cell disorders.
Divekar R; Butterfield J
Allergy; 2015 Oct; 70(10):1230-8. PubMed ID: 26095439
[TBL] [Abstract][Full Text] [Related]
3. Improved diagnosis of anaphylactoid reactions by measurement of serum tryptase and urinary methylhistamine.
Watkins J; Wild G
Ann Fr Anesth Reanim; 1993; 12(2):169-72. PubMed ID: 8368585
[No Abstract] [Full Text] [Related]
4. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
[TBL] [Abstract][Full Text] [Related]
5. Serum tryptase and SCORMA (SCORing MAstocytosis) Index as disease severity parameters in childhood and adult cutaneous mastocytosis.
Heide R; van Doorn K; Mulder PG; van Toorenenbergen AW; Beishuizen A; de Groot H; Tank B; Oranje AP
Clin Exp Dermatol; 2009 Jun; 34(4):462-8. PubMed ID: 19077102
[TBL] [Abstract][Full Text] [Related]
6. Gene expression analysis in mastocytosis reveals a highly consistent profile with candidate molecular markers.
D'ambrosio C; Akin C; Wu Y; Magnusson MK; Metcalfe DD
J Allergy Clin Immunol; 2003 Dec; 112(6):1162-70. PubMed ID: 14657877
[TBL] [Abstract][Full Text] [Related]
7. Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.
Vos BJ; van der Veer E; van Voorst Vader PC; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; de Monchy JG; van Doormaal JJ; Oude Elberink JN
J Allergy Clin Immunol; 2015 Mar; 135(3):792-8. PubMed ID: 25129675
[TBL] [Abstract][Full Text] [Related]
8. Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production.
Butterfield JH; Weiler CR
Int Arch Allergy Immunol; 2008; 147(4):338-43. PubMed ID: 18622141
[TBL] [Abstract][Full Text] [Related]
9. [Prospective epidemiologic study of perioperative anaphylactoid reactions occurring in Catalonia (1996-7)].
Escolano F; Valero A; Huguet J; Baxarias P; de Molina M; Castro A; Granel C; Sanosa J; Bartolomé B;
Rev Esp Anestesiol Reanim; 2002; 49(6):286-93. PubMed ID: 12353405
[TBL] [Abstract][Full Text] [Related]
10. Mast cell tryptase: a review of its physiology and clinical significance.
Payne V; Kam PC
Anaesthesia; 2004 Jul; 59(7):695-703. PubMed ID: 15200544
[TBL] [Abstract][Full Text] [Related]
11. Mast cell tryptase in sera of patients with Crohn's disease and mastocytosis.
de Rossi TM; Krauss N; Wilken V; Giera B; Konturek PC; Kressel J; Hahn EG; Raithel M
Eur J Gastroenterol Hepatol; 2009 Mar; 21(3):273-7. PubMed ID: 19279472
[TBL] [Abstract][Full Text] [Related]
12. Increased leukotriene E4 excretion in systemic mastocytosis.
Butterfield JH
Prostaglandins Other Lipid Mediat; 2010 Jun; 92(1-4):73-6. PubMed ID: 20380889
[TBL] [Abstract][Full Text] [Related]
13. Urinary N-methylhistamine as an indicator of bone marrow involvement in mastocytosis.
Oranje AP; Mulder PG; Heide R; Tank B; Riezebos P; van Toorenenbergen AW
Clin Exp Dermatol; 2002 Sep; 27(6):502-6. PubMed ID: 12372095
[TBL] [Abstract][Full Text] [Related]
14. Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions.
van Doormaal JJ; van der Veer E; van Voorst Vader PC; Kluin PM; Mulder AB; van der Heide S; Arends S; Kluin-Nelemans JC; Oude Elberink JN; de Monchy JG
Allergy; 2012 May; 67(5):683-90. PubMed ID: 22435702
[TBL] [Abstract][Full Text] [Related]
15. Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11β-prostaglandin2α.
Ravi A; Butterfield J; Weiler CR
J Allergy Clin Immunol Pract; 2014; 2(6):775-8. PubMed ID: 25439370
[TBL] [Abstract][Full Text] [Related]
16. [When the fluoro-immuno-enzymatic (FEIA) measurements turn out to be more sensitive than radioimmunologic (RIA) measurements. Application to the measurement of serum tryptase].
Sabbah A; Drouet M; Guittot M
Allerg Immunol (Paris); 1997 Oct; 29(8):239-41. PubMed ID: 9453735
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of tryptase in anaphylaxis and mastocytosis.
Schwartz LB
Immunol Allergy Clin North Am; 2006 Aug; 26(3):451-63. PubMed ID: 16931288
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers predictive for bone marrow involvement in systemic mastocytosis.
Donker ML; van Doormaal JJ; van Doormaal FF; Kluin PM; van der Veer E; de Monchy JG; Kema IP; Kluin-Nelemans HC
Haematologica; 2008 Jan; 93(1):120-3. PubMed ID: 18166795
[TBL] [Abstract][Full Text] [Related]
19. Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease.
Sperr WR; Jordan JH; Fiegl M; Escribano L; Bellas C; Dirnhofer S; Semper H; Simonitsch-Klupp I; Horny HP; Valent P
Int Arch Allergy Immunol; 2002 Jun; 128(2):136-41. PubMed ID: 12065914
[TBL] [Abstract][Full Text] [Related]
20. Measurement of urinary N tau-methylhistamine excretion: correlation of a newly developed radioimmunoassay (RIA) with gas chromatography mass spectrometry (GCMS).
Oosting E; Keyzer JJ
Agents Actions; 1991 May; 33(1-2):215-7. PubMed ID: 1897442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
